Cell And Gene Articles, App Notes, Case Studies, & White Papers
-
Streamline Analytical Tech Transfer Through Analytical Target Profile
9/9/2025
Analytics debt in CGT can derail timelines and budgets. Learn how early ATP planning and cross-functional alignment can eliminate costly setbacks and accelerate IND approvals.
-
Select The Best Analyte: A Guide To Effective Mycoplasma Testing
9/24/2025
As you build a Mycoplasma testing strategy to ensure drug safety, there are three analyte types to choose from: live Mycoplasma, RNA, and genomic DNA, each offering distinct advantages.
-
The Value Of Peptones For Enhancing Biopharmaceutical Productivity
11/18/2024
Peptones, versatile media additives derived from various sources, offer numerous benefits for biopharmaceutical production.
-
A Study To Assess Organoid Size And Cell Count From 3D Image Analysis
4/4/2025
Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.
-
A Beginner's Guide To Sf9 Culture In Stirred-Tank Bioreactors
7/9/2025
Learn about the workflow steps for Sf9 cell expansion, virus preparation, and protein production in stirred-tank bioreactors, including GFP expression.
-
NDA Success Strategy: Using Non-US Clinical Data In An NDA Submission
8/12/2025
A sponsor acquiring a therapeutic asset from an overseas company sought assistance when including foreign clinical trial dat,a generated outside a U.S. IND, in a New Drug Application (NDA).
-
Functional And Phenotypic Characterization Of Human NK Cells Post-Expansion
9/10/2025
A new method for expanding natural killer cells provides a way to generate a large quantity of potent cells for clinical applications. This approach maintains key cell functions and killing ability.
-
Advancing A LNP Formulation To Clinical And Commercial Manufacturing
3/25/2024
Lipid selection impacts the final LNP drug product and the LNP process. Review critical quality considerations for lipids and the process requirements for successful commercial-scale manufacturing.
-
Optimizing siRNA Therapeutics: Addressing Manufacturing Complexities
3/21/2025
Discover key strategies to optimize siRNA therapeutics by addressing critical nonclinical and manufacturing challenges for a smoother path to commercialization.
-
Mobilizing Compliance: USP 797 And 800 Pharmacy Trailer Fleet For VA Hospitals
6/6/2024
VA hospitals across the US are undergoing renovations to bring their facilities into compliance. The challenge was to design and manufacture a fleet of self-sufficient mobile compounding pharmacies.